More recently, we treated ThrbPV/PVPten+/−mice with a STAT3-specific inhibitor, S3I-201, aiming to block the STAT3-downstream signaling to delay obesity-exacerbated thyroid cancer progression [10]. This evidence concerns the gene STAT3 and thyroid cancer.